Research Article
Value of the Ratio of Monocytes to Lymphocytes for Monitoring Tuberculosis Therapy
Table 1
MLR of patients before treatment and on discharge in different subgroups.
| | N | Before treatment | On discharge | |
| Gender | | | | | Male | 90 | 0.50 (0.32–0.69) | 0.35 (0.26–0.54) | <0.001 | Female | 61 | 0.37 (0.24–0.62) | 0.30 (0.20–0.39) | <0.001 | Age | | | | <0.001 | <30 y | 75 | 0.47 (0.28–0.69) | 0.32 (0.26–0.46) | <0.001 | 30–55 y | 46 | 0.38 (0.25–0.61) | 0.29 (0.21–0.41) | <0.001 | >55 y | 30 | 0.47 (0.32–0.77) | 0.35 (0.23–0.59) | <0.001 | Location | | | | <0.001 | Pulmonary TB | 120 | 0.44 (0.26–0.45) | 0.32 (0.25–0.45) | <0.001 | Extrapulmonary TB | 31 | 0.49 (0.27–0.77) | 0.37 (0.24–0.48) | 0.001 |
|
|